SMAD3 is also involved in other cross-talks affecting AR regulation: Kollara et al., exploring the AR interactome, demonstrated that a ligand-independent interaction between AR and VEPH1 inhibits SMAD3 and p-Akt, resulting in a tumor boost caused by higher AR levels [68]. The gene discussed is AKT1; the disease is neoplasm.